Shape Therapeutics to Present Groundbreaking Advances in ADAR-Mediated RNA Editing in Parkinson’s Disease at the Jefferies Gene Therapy and Editing Summit

SEATTLE–(BUSINESS WIRE)–Shape Therapeutics, Inc. (ShapeTX), a pre-clinical stage company with an industry-leading RNA targeting technology platform, announced today that Francois Vigneault, PhD., President & Chief Executive Officer, will highlight advances in their RNAfix™ ADAR editing platform, including data that demonstrates RNA editing up to ~90% in genes implicated in Parkinson’s disease. The presentation will be on Friday, October 2, 2020 at 4 PM ET. The conference is being held vir